|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ropivacaine attenuates pulmonary vasoconstriction induced by thromboxane A2 analogue in the isolated perfused rat lung显示文摘 | Fischer LG Honemann CW Patrie JT | 2000 | Reg Anesth Pain Med2000，25，2： | 1 |
| 2 | Are survival and reproduction of Enchytraeus albidus (Anelia:Enchytraeidae) at risk by feeding on Bt-maize litter显示文摘 | Honemann L Zurbrugg C Nentwig W | 2009 | European Journal of Soil Biology2009，45，4： | 1 |
| 3 | Refinement of the Medicare diagnosis-related groups to incorporate a meas- ure of severity显示文摘 | Edwards N Honemann D Burley D | 1994 | Health care financing review1994，16，2： | 1 |
| 4 | Local anesthetics inhibit thromboxane A2 signaling in Xenopus oocytes and human k562 cells显示文摘 | Honemann C W Hahnenkamp K Podranski T | 2004 | Anesth Analg2004，99，3： | 1 |
| 5 | Ropivacaine attenuates Pulmonary vasoconstriction induced by thromboxane A2 analogue in the isolated perfused rat lung显示文摘 | Fischer LG Honemann CW Pattie JT et ai | 2000 | Reg Anesth Pain Med2000，25，2： | 1 |
| 6 | Ropivacaine attenuates pulmonary vasoconstriction induced by thromboxane A2 analogue in the isolated perfused rat lung 显示文摘 | Fischer LG Honemann CW Pattie JT | 2000 | Reg Anesth Pain Med2000，25，2： | 1 |
| 7 | In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL - 6/gp130/STAT3 pathway 显示文摘 | Chatterjee M Honemann D Lentzsch S | 2002 | Blood2002，100，9： | 1 |
| 8 | In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gpl30/Stat3 path-way显示文摘 | Chatterjee M Honemann D Lentzsch S | 2007 | Blood2007，100，9： | 1 |
| 9 | Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetyleholine receptor function显示文摘 | IETGEN G W HONEMANN C W CHAN C K | 1998 | Br J Anaesth1998，81，5： | 1 |
| 10 | In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6 / gp130 / STAT3 pathway显示文摘 | Chatterjee M Honemann D Lentzsch S | 2002 | Blood2002，100，8： | 1 |
| 11 | Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57^+ cytotoxic T cells as predictors of outcome 显示文摘 | Mileshkin L Honemann D Gambell P | 2007 | Haematologica2007，92，6： | 1 |
| 12 | The IL - 6 receptor antag- onist sant - 7 overcomes bone marrow stromal cell - mediated drug re- sistance of Multiple Myeloma cells 显示文摘 | Honemann D Chatterjee M Savino R | | Inernational Journal of Cancer0，93，5： | 1 |
| 13 | A novel recombinant bispecific single-chain antibody,bscWue-1xCD3,induces T-cell-mediated cytotoxicity towards human multiple myeloma cells显示文摘 | Honemann D Kuffer P Rimpler M M | 2004 | Leukemia2004，18，3： | 1 |
| 14 | A novel recombinant bispecific single-chain antibody,bscWue-1 x CD3,induces T-cell-mediated cytotoxicity towards human multiple myeloma cells显示文摘 | Honemann Kufer Rimpler | 2004 | Leukemia2004，18，3： | 1 |
| 15 | Effects of Bt-corn decomposition on the composition of the soil meso-and macrofauna显示文摘 | Honemann L Zurbrugg C Nentwig W | 2008 | Applied Soil Ecology2008，40，： | 1 |
| 16 | Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57+cytotoxic T cells as predictors of outcome显示文摘 | Mileshkin L Honemann D Gambell P | 2007 | Haematologica2007，92，8： | 1 |
| 17 | Patients with multiple myeloma treated with thalidomide:evaluation of clinical parameters,cytokines,angiogenic markers,mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome显示文摘 | Mileshkin L Honemann D Gambell P | | 0，，08： | 1 |
| 18 | In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL- 8 / gp130 / STAT3 pahtway显示文摘 | Chatterjee M Honemann D Lentsch S | 2002 | Blood2002，100，： | 1 |
| 19 | A novel recombinant bispecific single-chain antibody, bscWue-1 x CD3, induces T-cellmediated cytotoxicity towards human multiple myeloma cells显示文摘 | Honemann D Kufer P Rimpler MM | 2004 | Leukemia2004，18，3： | 1 |
| 20 | Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, eytokines, angiogenic markers, mast cells and marrow CD57 + cy- totoxic T cells as predictors of outcome显示文摘 | Mileshkin L Honemann D Gambell P | 2007 | Haematologiea2007，92，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员